Treat to Target ASCVD Risk with Oral Non-statins and Bempedoic Acid: DELPHI Statement. ccm. 2023;7(4):265-272. Accessed September 17, 2026. https://fortunejournals.org/ojs/index.php/ccm/article/view/16422